Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)
China · Delayed Price · Currency is CNY 59.68
+1.23 (2.10%)
At close: Aug 1, 2025, 2:57 PM CST
Elevation Oncology Market Cap
SHE:301096 has a market cap or net worth of 6.47 billion as of August 1, 2025. Its market cap has increased by 13.12% in one year.
Market Cap
6.47B
Enterprise Value
6.79B
Revenue
714.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
$59.68
Market Cap Chart
Since December 20, 2021, SHE:301096's market cap has decreased from 10.93B to 6.47B, a decrease of -40.80%. That is a compound annual growth rate of -13.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 6.47B | 57.30% |
| Dec 31, 2024 | 4.11B | -41.97% |
| Dec 29, 2023 | 7.09B | -4.04% |
| Dec 30, 2022 | 7.39B | -20.49% |
| Dec 31, 2021 | 9.29B | -15.01% |
| Dec 20, 2021 | 10.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 424.16B |
| Shenzhen Mindray Bio-Medical Electronics | 287.79B |
| WuXi AppTec | 282.67B |
| Sichuan Biokin Pharmaceutical | 130.49B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.22B |
| Aier Eye Hospital Group | 122.33B |
| Shanghai United Imaging Healthcare | 112.35B |
| Yunnan Baiyao Group Co.,Ltd | 102.45B |